In a recent report, “Bacteriophage Market - Growth, Future, Competitive Analysis, 2018-2026,” published by the American company Credence Research, the global bacteriophage market in 2017 was valued at US$567 million and is projected to grow at a CAGR of 3.9%.

The report notes that bacteriophages (phages) are now considered an important tool in modern biotechnology, as well as an alternative to antibiotics for the treatment of antibiotic-resistant infections. Phages can also be used for biological control in agriculture and the energy sector, particularly for the control of bacterial corrosion in gas pipelines.

Bacteriophages can be used as vaccine delivery vehicles, for detecting pathogenic bacteria in various environments, and as the basis for biosensors and phage display technology.

Phages can not only destroy bacteria, but also transfer genetic information between them. Therefore, their study will help in understanding the mechanisms of genome evolution, bacterial evolution, DNA expression and, accordingly, will serve the creation of new biotechnologies.

The global rise in antibiotic-resistant pathogenic bacteria is stimulating the use of phages in medicine. When used clinically, specific phages do not affect eukaryotic cells or destroy normal human microflora.

An important area of application for phages is the food industry, where phage preparations are used for antimicrobial treatment of food products and equipment.

The bacteriophage market is divided into the following segments: single-stranded DNA (ssDNA), double-stranded DNA (dsDNA), and single-stranded RNA (ssRNA) phages. In 2017, dsDNA phages led the market and are expected to continue to dominate.

Geographically, the majority of the bacteriophage market is concentrated in the United States due to the abundance of companies researching and producing phages, the fastest commercialization process, and the large number of patients with antibiotic-resistant infections. The report also notes the dynamic growth of the bacteriophage market in the Asia-Pacific region, particularly due to government initiatives.

Key trends in the bacteriophage market:

- Growth of scientific research in the field of phage therapy for clinical application;

- Continuation of clinical trials of bacteriophages for the treatment of antibiotic-resistant infections and approval of phage preparations by regulatory authorities;

- Increased use of bacteriophages in the food industry, environmental protection, and veterinary medicine;

- Continuing research into the use of bacteriophages as effective means of vaccine delivery.

More details: https://www.credenceresearch.com/report/bacteriophage-market